Sort   by:  
 Page size 
UnknownOutcomes and characteristics of patients hospitalized for COVID-19 in British Columbia, Ontario and Quebec during the Omicron wave.
Not available
S-EPMC10400083 | biostudies-literature
UnknownOrgan dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort study.
Not available
S-EPMC9022939 | biostudies-literature
UnknownPharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis.
Not available
S-EPMC5792380 | biostudies-literature
ProteomicsLongitudinal Plasma Proteomics Analysis of Acute COVID-19
The host response to COVID-19 pathophysiology over the first days of infection remains largely unclear especially the mechanisms in the blood compartment. We report here on a longitudinal proteomic analysis of acute phase COVID-19 patients, for which we used blood plasma and MRM proteomics with inte...
ORGANISM(S): Homo sapiens (Human) 
2022-02-16 | PXD029437 | Pride
Covid-19 Longitudinal analysis Amyloid Complement Acei Targeted quantitative proteomics Arb 
UnknownThe design and rationale of SAVE BC: The Study to Avoid CardioVascular Events in British Columbia.
Not available
S-EPMC6490105 | biostudies-literature
ProteomicsPROTEOMICS EVOLUTION FROM ACUTE TO POST-COVID-19 CONDITION
We performed longitudinal plasma proteomics analysis and determined absolute protein levels in a Canadian cohort (n=74) at admission day to hospital for acute COVID-19 and at 3 and 6 months after diagnosis of acute COVID-19. We measured plasma protein on a triple quadrupole mass spectrometer operate...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD041762 | Pride
Covid-19 Restrictive lung disease Post-covid-19 condition Targeted proteomics 
UnknownAngiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors.
Not available
S-EPMC8023793 | biostudies-literature
UnknownUsing a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia.
Not available
S-EPMC10900651 | biostudies-literature
UnknownEarly increases in anti-SARS-CoV-2 antibody isotypes associated with organ dysfunction and mortality in patients hospitalized with COVID-19.
Not available
S-EPMC8975731 | biostudies-literature
UnknownRenin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19.
Not available
S-EPMC9380153 | biostudies-literature
Sort   by:  
 Page size